▶ 調査レポート

心筋症の世界市場:市場規模・現状・予測

• 英文タイトル:Global Cardiomyopathy Market Size, Status and Forecast 2019-2025

QYResearchが調査・発行した産業分析レポートです。心筋症の世界市場:市場規模・現状・予測 / Global Cardiomyopathy Market Size, Status and Forecast 2019-2025 / QYR9ST04756資料のイメージです。• レポートコード:QYR9ST04756
• 出版社/出版日:QYResearch / 2019年9月2日
※2024年版があります。お問い合わせください。

• レポート形態:英文、PDF、91ページ
• 納品方法:Eメール(受注後2-3営業日)
• 産業分類:医療・製薬
• 販売価格(消費税別)
  Single User¥577,200 (USD3,900)▷ お問い合わせ
  Enterprise License¥1,154,400 (USD7,800)▷ お問い合わせ
• ご注文方法:お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法:銀行振込(納品後、ご請求書送付)
レポート概要
※当調査レポートでは、心筋症の世界市場について調査・分析し、心筋症の世界市場規模、市場動向、主要企業別マーケットシェア、主要地域別市場規模、企業プロフィールなどの情報をまとめました。また、セグメント分析では、種類別(拡張型心筋症、肥大型心筋症、拘束型心筋症)、用途別(病院および診断センター、携帯電話サービスセンター)、地域別(北米、ヨーロッパ、中国、日本国内、東南アジア、インド、中南米)に区分して市場規模を算出しました。


・レポートの概要
・世界の心筋症市場動向
・主要企業別マーケットシェア
・心筋症の種類別市場規模2014-2019
(拡張型心筋症、肥大型心筋症、拘束型心筋症)
・心筋症の用途別市場規模2014-2019
(病院および診断センター、携帯電話サービスセンター)
・心筋症の北米市場:主要企業・種類別/用途別市場規模
・心筋症のヨーロッパ市場:主要企業・種類別/用途別市場規模
・心筋症の中国市場:主要企業・種類別/用途別市場規模
・心筋症の日本国内市場:主要企業・種類別/用途別市場規模
・心筋症の東南アジア市場:主要企業・種類別/用途別市場規模
・心筋症のインド市場:主要企業・種類別/用途別市場規模
・心筋症の中南米市場:主要企業・種類別/用途別市場規模
・主要企業のプロフィール
(Array BioPharma、Boston Scientific、Cisbio、Covance、Critical Diagnostics、Mylan、Pfizer、Becton Dickinson、BG Medicine、BioMérieux、Bio-Rad)
・心筋症の市場規模予測2019-2025
(種類別、用途別、地域別市場予測)
・アナリストの観点・結論
...

Cardiomyopathy refers to diseases of the heart muscleThe major factors that contributes in the growth of the market are advancement in understanding and managing cardiomyopathy and rise in incidences of congestive heart failure, coronary heart disease, and heart attack. Further, increasing trend of minimally invasive technology and availability of remote monitoring solutions are estimated to contribute in the growth of the market.
In 2018, the global Cardiomyopathy market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.

This report focuses on the global Cardiomyopathy status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Cardiomyopathy development in United States, Europe and China.

The key players covered in this study
Array BioPharma
Boston Scientific
Cisbio
Covance
Critical Diagnostics
Mylan
Pfizer
Becton Dickinson
BG Medicine
BioMérieux
Bio-Rad

Market segment by Type, the product can be split into
Dilated cardiomyopathy
Hypertrophic cardiomyopathy
Restrictive cardiomyopathy

Market segment by Application, split into
Hospitals and diagnostic centers
Ambulatory services centers

Market segment by Regions/Countries, this report covers
United States
Europe
China
Japan
Southeast Asia
India
Central & South America

The study objectives of this report are:
To analyze global Cardiomyopathy status, future forecast, growth opportunity, key market and key players.
To present the Cardiomyopathy development in United States, Europe and China.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.

In this study, the years considered to estimate the market size of Cardiomyopathy are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

レポート目次

Table of Contents

1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered
1.4 Market Analysis by Type
1.4.1 Global Cardiomyopathy Market Size Growth Rate by Type (2014-2025)
1.4.2 Dilated cardiomyopathy
1.4.3 Hypertrophic cardiomyopathy
1.4.4 Restrictive cardiomyopathy
1.5 Market by Application
1.5.1 Global Cardiomyopathy Market Share by Application (2014-2025)
1.5.2 Hospitals and diagnostic centers
1.5.3 Ambulatory services centers
1.6 Study Objectives
1.7 Years Considered

2 Global Growth Trends
2.1 Cardiomyopathy Market Size
2.2 Cardiomyopathy Growth Trends by Regions
2.2.1 Cardiomyopathy Market Size by Regions (2014-2025)
2.2.2 Cardiomyopathy Market Share by Regions (2014-2019)
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Opportunities

3 Market Share by Key Players
3.1 Cardiomyopathy Market Size by Manufacturers
3.1.1 Global Cardiomyopathy Revenue by Manufacturers (2014-2019)
3.1.2 Global Cardiomyopathy Revenue Market Share by Manufacturers (2014-2019)
3.1.3 Global Cardiomyopathy Market Concentration Ratio (CR5 and HHI)
3.2 Cardiomyopathy Key Players Head office and Area Served
3.3 Key Players Cardiomyopathy Product/Solution/Service
3.4 Date of Enter into Cardiomyopathy Market
3.5 Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type and Application
4.1 Global Cardiomyopathy Market Size by Type (2014-2019)
4.2 Global Cardiomyopathy Market Size by Application (2014-2019)

5 United States
5.1 United States Cardiomyopathy Market Size (2014-2019)
5.2 Cardiomyopathy Key Players in United States
5.3 United States Cardiomyopathy Market Size by Type
5.4 United States Cardiomyopathy Market Size by Application

6 Europe
6.1 Europe Cardiomyopathy Market Size (2014-2019)
6.2 Cardiomyopathy Key Players in Europe
6.3 Europe Cardiomyopathy Market Size by Type
6.4 Europe Cardiomyopathy Market Size by Application

7 China
7.1 China Cardiomyopathy Market Size (2014-2019)
7.2 Cardiomyopathy Key Players in China
7.3 China Cardiomyopathy Market Size by Type
7.4 China Cardiomyopathy Market Size by Application

8 Japan
8.1 Japan Cardiomyopathy Market Size (2014-2019)
8.2 Cardiomyopathy Key Players in Japan
8.3 Japan Cardiomyopathy Market Size by Type
8.4 Japan Cardiomyopathy Market Size by Application

9 Southeast Asia
9.1 Southeast Asia Cardiomyopathy Market Size (2014-2019)
9.2 Cardiomyopathy Key Players in Southeast Asia
9.3 Southeast Asia Cardiomyopathy Market Size by Type
9.4 Southeast Asia Cardiomyopathy Market Size by Application

10 India
10.1 India Cardiomyopathy Market Size (2014-2019)
10.2 Cardiomyopathy Key Players in India
10.3 India Cardiomyopathy Market Size by Type
10.4 India Cardiomyopathy Market Size by Application

11 Central & South America
11.1 Central & South America Cardiomyopathy Market Size (2014-2019)
11.2 Cardiomyopathy Key Players in Central & South America
11.3 Central & South America Cardiomyopathy Market Size by Type
11.4 Central & South America Cardiomyopathy Market Size by Application

12 International Players Profiles
12.1 Array BioPharma
12.1.1 Array BioPharma Company Details
12.1.2 Company Description and Business Overview
12.1.3 Cardiomyopathy Introduction
12.1.4 Array BioPharma Revenue in Cardiomyopathy Business (2014-2019)
12.1.5 Array BioPharma Recent Development
12.2 Boston Scientific
12.2.1 Boston Scientific Company Details
12.2.2 Company Description and Business Overview
12.2.3 Cardiomyopathy Introduction
12.2.4 Boston Scientific Revenue in Cardiomyopathy Business (2014-2019)
12.2.5 Boston Scientific Recent Development
12.3 Cisbio
12.3.1 Cisbio Company Details
12.3.2 Company Description and Business Overview
12.3.3 Cardiomyopathy Introduction
12.3.4 Cisbio Revenue in Cardiomyopathy Business (2014-2019)
12.3.5 Cisbio Recent Development
12.4 Covance
12.4.1 Covance Company Details
12.4.2 Company Description and Business Overview
12.4.3 Cardiomyopathy Introduction
12.4.4 Covance Revenue in Cardiomyopathy Business (2014-2019)
12.4.5 Covance Recent Development
12.5 Critical Diagnostics
12.5.1 Critical Diagnostics Company Details
12.5.2 Company Description and Business Overview
12.5.3 Cardiomyopathy Introduction
12.5.4 Critical Diagnostics Revenue in Cardiomyopathy Business (2014-2019)
12.5.5 Critical Diagnostics Recent Development
12.6 Mylan
12.6.1 Mylan Company Details
12.6.2 Company Description and Business Overview
12.6.3 Cardiomyopathy Introduction
12.6.4 Mylan Revenue in Cardiomyopathy Business (2014-2019)
12.6.5 Mylan Recent Development
12.7 Pfizer
12.7.1 Pfizer Company Details
12.7.2 Company Description and Business Overview
12.7.3 Cardiomyopathy Introduction
12.7.4 Pfizer Revenue in Cardiomyopathy Business (2014-2019)
12.7.5 Pfizer Recent Development
12.8 Becton Dickinson
12.8.1 Becton Dickinson Company Details
12.8.2 Company Description and Business Overview
12.8.3 Cardiomyopathy Introduction
12.8.4 Becton Dickinson Revenue in Cardiomyopathy Business (2014-2019)
12.8.5 Becton Dickinson Recent Development
12.9 BG Medicine
12.9.1 BG Medicine Company Details
12.9.2 Company Description and Business Overview
12.9.3 Cardiomyopathy Introduction
12.9.4 BG Medicine Revenue in Cardiomyopathy Business (2014-2019)
12.9.5 BG Medicine Recent Development
12.10 BioMérieux
12.10.1 BioMérieux Company Details
12.10.2 Company Description and Business Overview
12.10.3 Cardiomyopathy Introduction
12.10.4 BioMérieux Revenue in Cardiomyopathy Business (2014-2019)
12.10.5 BioMérieux Recent Development
12.11 Bio-Rad

13 Market Forecast 2019-2025
13.1 Market Size Forecast by Regions
13.2 United States
13.3 Europe
13.4 China
13.5 Japan
13.6 Southeast Asia
13.7 India
13.8 Central & South America
13.9 Market Size Forecast by Product (2019-2025)
13.10 Market Size Forecast by Application (2019-2025)

14 Analyst’s Viewpoints/Conclusions

15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
12.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Disclaimer
15.3 Author Details

List of Tables and Figures

Table Cardiomyopathy Key Market Segments
Table Key Players Cardiomyopathy Covered
Table Global Cardiomyopathy Market Size Growth Rate by Type 2014-2025 (Million US$)
Figure Global Cardiomyopathy Market Size Market Share by Type 2014-2025
Figure Dilated cardiomyopathy Figures
Table Key Players of Dilated cardiomyopathy
Figure Hypertrophic cardiomyopathy Figures
Table Key Players of Hypertrophic cardiomyopathy
Figure Restrictive cardiomyopathy Figures
Table Key Players of Restrictive cardiomyopathy
Table Global Cardiomyopathy Market Size Growth by Application 2014-2025 (Million US$)
Figure Hospitals and diagnostic centers Case Studies
Figure Ambulatory services centers Case Studies
Figure Cardiomyopathy Report Years Considered
Table Global Cardiomyopathy Market Size 2014-2025 (Million US$)
Figure Global Cardiomyopathy Market Size and Growth Rate 2014-2025 (Million US$)
Table Global Cardiomyopathy Market Size by Regions 2014-2025 (Million US$)
Table Global Cardiomyopathy Market Size by Regions 2014-2019 (Million US$)
Table Global Cardiomyopathy Market Share by Regions 2014-2019
Figure Global Cardiomyopathy Market Share by Regions 2014-2019
Figure Global Cardiomyopathy Market Share by Regions 2019
Table Market Top Trends
Table Global Cardiomyopathy Revenue by Manufacturers (2014-2019) (Million US$)
Table Global Cardiomyopathy Market Share by Manufacturers (2014-2019)
Figure Global Cardiomyopathy Market Share by Manufacturers in 2018
Table Global Cardiomyopathy Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Key Players Head office and Area Served
Table Key Players Cardiomyopathy Product/Solution/Service
Table Date of Enter into Cardiomyopathy Market
Table Mergers & Acquisitions, Expansion Plans
Table Global Cardiomyopathy Market Size by Type (2014-2019) (Million US$)
Table Global Cardiomyopathy Market Size Share by Type (2014-2019)
Figure Global Cardiomyopathy Market Size Market Share by Type (2014-2019)
Table Global Cardiomyopathy Market Size by Application (2014-2019) (Million US$)
Table Global Cardiomyopathy Market Size Share by Application (2014-2019)
Figure Global Cardiomyopathy Market Size Market Share by Application (2014-2019)
Figure Global Cardiomyopathy Revenue Market Share by Application in 2018
Figure United States Cardiomyopathy Market Size 2014-2019 (Million US$)
Table United States Key Players Cardiomyopathy Revenue (2018-2019) (Million US$)
Table United States Key Players Cardiomyopathy Market Share (2018-2019)
Table United States Cardiomyopathy Market Size by Type (2014-2019) (Million US$)
Table United States Cardiomyopathy Market Share by Type (2014-2019)
Table United States Cardiomyopathy Market Size by Application (2014-2019) (Million US$)
Table United States Cardiomyopathy Market Share by Application (2014-2019)
Figure Europe Cardiomyopathy Market Size 2014-2019 (Million US$)
Table Europe Key Players Cardiomyopathy Revenue (2018-2019) (Million US$)
Table Europe Key Players Cardiomyopathy Market Share (2018-2019)
Table Europe Cardiomyopathy Market Size by Type (2014-2019) (Million US$)
Table Europe Cardiomyopathy Market Share by Type (2014-2019)
Table Europe Cardiomyopathy Market Size by Application (2014-2019) (Million US$)
Table Europe Cardiomyopathy Market Share by Application (2014-2019)
Figure China Cardiomyopathy Market Size 2014-2019 (Million US$)
Table China Key Players Cardiomyopathy Revenue (2018-2019) (Million US$)
Table China Key Players Cardiomyopathy Market Share (2018-2019)
Table China Cardiomyopathy Market Size by Type (2014-20189) (Million US$)
Table China Cardiomyopathy Market Share by Type (2014-2019)
Table China Cardiomyopathy Market Size by Application (2014-2019) (Million US$)
Table China Cardiomyopathy Market Share by Application (2014-2019)
Figure Japan Cardiomyopathy Market Size 2014-2019 (Million US$)
Table Japan Key Players Cardiomyopathy Revenue (2018-2019) (Million US$)
Table Japan Key Players Cardiomyopathy Market Share (2018-2019)
Table Japan Cardiomyopathy Market Size by Type (2014-2019) (Million US$)
Table Japan Cardiomyopathy Market Share by Type (2014-2019)
Table Japan Cardiomyopathy Market Size by Application (2014-2019) (Million US$)
Table Japan Cardiomyopathy Market Share by Application (2014-2019)
Figure Southeast Asia Cardiomyopathy Market Size 2014-2019 (Million US$)
Table Southeast Asia Key Players Cardiomyopathy Revenue (2018-2019) (Million US$)
Table Southeast Asia Key Players Cardiomyopathy Market Share (2018-2019)
Table Southeast Asia Cardiomyopathy Market Size by Type (2014-2019) (Million US$)
Table Southeast Asia Cardiomyopathy Market Share by Type (2014-2019)
Table Southeast Asia Cardiomyopathy Market Size by Application (2014-2019) (Million US$)
Table Southeast Asia Cardiomyopathy Market Share by Application (2014-2019)
Figure India Cardiomyopathy Market Size 2014-2019 (Million US$)
Table India Key Players Cardiomyopathy Revenue (2018-2019) (Million US$)
Table India Key Players Cardiomyopathy Market Share (2018-2019)
Table India Cardiomyopathy Market Size by Type (2014-2019) (Million US$)
Table India Cardiomyopathy Market Share by Type (2014-2019)
Table India Cardiomyopathy Market Size by Application (2014-2019) (Million US$)
Table India Cardiomyopathy Market Share by Application (2014-2019)
Figure Central & South America Cardiomyopathy Market Size 2014-2019 (Million US$)
Table Central & South America Key Players Cardiomyopathy Revenue (2018-2019) (Million US$)
Table Central & South America Key Players Cardiomyopathy Market Share (2018-2019)
Table Central & South America Cardiomyopathy Market Size by Type (2014-2019) (Million US$)
Table Central & South America Cardiomyopathy Market Share by Type (2014-2019)
Table Central & South America Cardiomyopathy Market Size by Application (2014-2019) (Million US$)
Table Central & South America Cardiomyopathy Market Share by Application (2014-2019)
Table Array BioPharma Company Details
Table Array BioPharma Revenue in Cardiomyopathy Business (2014-2019) (Million US$)
Figure Array BioPharma Revenue Growth Rate in Cardiomyopathy Business (2014-2019)
Table Array BioPharma Recent Development
Table Boston Scientific Company Details
Table Boston Scientific Revenue in Cardiomyopathy Business (2014-2019)(Million US$)
Figure Boston Scientific Revenue Growth Rate in Cardiomyopathy Business (2014-2019)
Table Boston Scientific Recent Development
Table Cisbio Company Details
Table Cisbio Revenue in Cardiomyopathy Business (2014-2019)(Million US$)
Figure Cisbio Revenue Growth Rate in Cardiomyopathy Business (2014-2019)
Table Cisbio Recent Development
Table Covance Company Details
Table Covance Revenue in Cardiomyopathy Business (2014-2019)(Million US$)
Figure Covance Revenue Growth Rate in Cardiomyopathy Business (2014-2019)
Table Covance Recent Development
Table Critical Diagnostics Company Details
Table Critical Diagnostics Revenue in Cardiomyopathy Business (2014-2019)(Million US$)
Figure Critical Diagnostics Revenue Growth Rate in Cardiomyopathy Business (2014-2019)
Table Critical Diagnostics Recent Development
Table Mylan Company Details
Table Mylan Revenue in Cardiomyopathy Business (2014-2019)(Million US$)
Figure Mylan Revenue Growth Rate in Cardiomyopathy Business (2014-2019)
Table Mylan Recent Development
Table Pfizer Company Details
Table Pfizer Revenue in Cardiomyopathy Business (2014-2019)(Million US$)
Figure Pfizer Revenue Growth Rate in Cardiomyopathy Business (2014-2019)
Table Pfizer Recent Development
Table Becton Dickinson Company Details
Table Becton Dickinson Revenue in Cardiomyopathy Business (2014-2019)(Million US$)
Figure Becton Dickinson Revenue Growth Rate in Cardiomyopathy Business (2014-2019)
Table Becton Dickinson Recent Development
Table BG Medicine Company Details
Table BG Medicine Revenue in Cardiomyopathy Business (2014-2019)(Million US$)
Figure BG Medicine Revenue Growth Rate in Cardiomyopathy Business (2014-2019)
Table BG Medicine Recent Development
Table BioMérieux Company Details
Table BioMérieux Revenue in Cardiomyopathy Business (2014-2019)(Million US$)
Figure BioMérieux Revenue Growth Rate in Cardiomyopathy Business (2014-2019)
Table BioMérieux Recent Development
Table Bio-Rad Company Details
Table Global Cardiomyopathy Market Size by Regions (Million US$) 2019-2025
Figure Global Cardiomyopathy Market Size Share by Regions (2019-2025)
Figure Global Cardiomyopathy Market Size Share by Regions in 2025
Figure United States Cardiomyopathy Market Size Forecast (2019-2025)(Million USD)
Figure Europe Cardiomyopathy Market Size Forecast (2019-2025)(Million USD)
Figure China Cardiomyopathy Market Size Forecast (2019-2025)(Million USD)
Figure Japan Cardiomyopathy Market Size Forecast (2019-2025)(Million USD)
Figure Southeast Asia Cardiomyopathy Market Size Forecast (2019-2025)(Million USD)
Figure India Cardiomyopathy Market Size Forecast (2019-2025)(Million USD)
Figure Central & South America Cardiomyopathy Market Size Forecast (2019-2025)(Million USD)
Table Global Cardiomyopathy Market Size by Product (2019-2025) (Million US$)
Figure Global Cardiomyopathy Market Size by Product (2019-2025)
Figure Global Cardiomyopathy Market Size by Product in 2025
Table Global Cardiomyopathy Market Size by Application (2019-2025) (Million US$)
Figure Global Cardiomyopathy Market Size by Application (2019-2025)
Figure Global Cardiomyopathy Market Size by Application in 2025
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources